19 February 2020
  • Share

Deirdre Sanders, president of the Boston Patent Law Association and a principle at Hamilton Brook Smith Reynolds, writes for Forward magazine. 

Although Massachusetts is one of the smaller US states, it has one of the bigger roles in life sciences and biotechnology innovation. According to the latest data available from the United States Patent and Trademark Office, Massachusetts ranks fourth in the nation - behind only the significantly larger states of California, New York and Texas - in terms of the total number of patents granted.

Of course, its world-famous research institutions play a major role. Massachusetts is home to a number of the most innovative universities in the world, including Harvard University, Massachusetts Institute of Technology (MIT) and Tufts University. In addition, four Massachusetts hospitals are among those receiving the most funding from the US National Institutes of Health (NIH) - the world's largest public funder of biomedical research. These institutions often generate the research that results in novel inventions and that leads to the formation of breakthrough startups.

However, these universities and hospitals are just one part of the symbiotic ecosystem that is the real driving force for innovation. This ecosystem is well supported by local government partnerships such as the Massachusetts Life Sciences Center, an economic development and investment agency supporting life sciences in the state, which has released funding worth more than US$670m since 2007. This includes research grants, accelerator loans, capital infrastructure investments, tax incentives and workforce programmes. Meanwhile, a number of local life science incubators and organisations provide workspace, equipment and much-needed support to startups.

Private investors are also essential. Massachusetts receives some of the highest levels of venture capital funding in the US. According to the Massachusetts Biotechnology Council (MassBio), biopharma companies in the state received more than US$4.8bn in venture capital in 2018. Funding also flows from other sources, including angel investment groups and financial institutions.

Crucially, local associations and organisations help to bring together these elements and provide a sense of community, often working in partnership. In addition
to MassBio, the Boston Patent Law Association (BPLA), the MIT Enterprise Forum, the Venture Forum and the New England Business Association are just a few of those supporting innovative entrepreneurs.

As president of the BPLA, I am proud to be part of this effort. The BPLA provides a forum for the exchange of ideas and information regarding IP by holding educational seminars, social meetups and community events, such as our Invented Here! programme to honour local inventors. We also educate members of the government about the IP issues that are of importance to innovators by providing amicus briefs, regulatory comments and feedback to local and federal policymakers.

So Massachusetts' life science innovation success may start with world-class research, but it flourishes thanks to the commitment, support and encouragement of its multifaceted ecosystem.

Guest author - Deirdre Sanders

Deirdre is president of the Boston Patent Law Association and a principle at Hamilton Brook Smith Reynolds. She has 20 years of experience in strategic biotechnology patent prosecution counseling and in intellectual property litigation and enforcement.

third-edition

 

 

 

 

 

 

 

 

 

This article was originally published in the third edition of Mewburn Ellis Forward — a biannual publication that celebrates the best of innovation and exploration.

Subscribe to Mewburn Ellis Forward here.

 

 

 

Sarah has extensive experience in the drafting and prosecution of patent applications, predominantly in the pharmaceutical sector but with a sizeable materials chemistry practice. Sarah also has both offensive and defensive opposition experience and defended several patents covering approved medicines in the EPO’s Opposition procedure. Sarah has a first class MChem chemistry degree from the University of Oxford and a PhD in organic synthesis from the University of Southampton. Her doctorate research focused on the total synthesis of natural products using radical-based approaches. She spent two years conducting postdoctoral research in Southampton, and has also undertaken a research placement with a pharmaceutical process chemistry team.
Comments

Sign up to our newsletter: Forward - news, insights and features

Our People

Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.

OUR PEOPLE

Contact Us

We have an easily-accessible office in central London, as well as a number of regional offices throughout the UK and an office in Munich, Germany.  We’d love to hear from you, so please get in touch.